<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">West J Emerg Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">West J Emerg Med</journal-id>
      <journal-id journal-id-type="publisher-id">WestJEM</journal-id>
      <journal-title-group>
        <journal-title>Western Journal of Emergency Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1936-900X</issn>
      <issn pub-type="epub">1936-9018</issn>
      <publisher>
        <publisher-name>Department of Emergency Medicine, University of California, Irvine School of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25035738</article-id>
      <article-id pub-id-type="pmc">4100838</article-id>
      <article-id pub-id-type="doi">10.5811/westjem.2014.4.20571</article-id>
      <article-id pub-id-type="publisher-id">wjem-15-382</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Diagnostic Acumen</subject>
          <subj-group subj-group-type="heading">
            <subject>Case Report</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bilateral Hydronephrosis and Cystitis Resulting from</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Abuse</surname>
            <given-names>Chronic Ketamine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tran</surname>
            <given-names>Vu Huy</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="af1-wjem-15-382">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nelson</surname>
            <given-names>Mathew</given-names>
          </name>
          <degrees>DO</degrees>
          <xref ref-type="aff" rid="af2-wjem-15-382">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nogar</surname>
            <given-names>Joshua</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="af2-wjem-15-382">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bramante</surname>
            <given-names>Robert M.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="af2-wjem-15-382">&#x2020;</xref>
          <xref ref-type="corresp" rid="c1-wjem-15-382"/>
        </contrib>
      </contrib-group>
      <aff id="af1-wjem-15-382"><label>*</label>Albert Einstein College of Medicine, Jack D. Weiler Hospital, Bronx, New York</aff>
      <aff id="af2-wjem-15-382"><label>&#x2020;</label>Hofstra North Shore-LIJ School of Medicine, Department of Emergency Medicine, Hempstead, New York</aff>
      <author-notes>
        <corresp id="c1-wjem-15-382">Address for Correspondence: Robert M. Bramante, MD. Hofstra North Shore-LIJ Medical Center Department of Emergency Medicine, 300 Community Drive, Manhasset, NY 11030. Email: <email>rbramante@nshs.edu</email>.</corresp>
        <fn id="fn1-wjem-15-382">
          <p><italic>Supervising Section Editor:</italic> Rick A. McPheeters, DO</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <volume>15</volume>
      <issue>4</issue>
      <fpage>382</fpage>
      <lpage>384</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>11</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 the authors.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Non-Commercial Attribution License, which permits its use in any digital medium, provided the original work is properly cited and not altered. For details, please refer to <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>. Authors grant Western Journal of Emergency Medicine a nonexclusive license to publish the manuscript.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Ketamine associated urinary dysfunction has become increasingly more common worldwide. Point-of-care ultrasound (POCUS) is an established modality for diagnosing hydronephrosis in the emergency department. We describe a case of a young male ketamine abuser with severe urinary urgency and frequency in which POCUS performed by the emergency physician demonstrated bilateral hydronephrosis and a focally thickened irregular shaped bladder. Emergency physicians should consider using POCUS evaluate for hydronephrosis and bladder changes in ketamine abusers with lower urinary tract symptoms. The mainstay of treatment is discontinuing ketamine abuse.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Ketamine induced urinary dysfunction (KAUD) is a syndrome first described in the literature in 2007. Patients suffer from irritative lower urinary tract symptoms and can develop varying degrees of hydronephrosis and interstitial cystitis. We describe a case of a young man with a history of heavy ketamine abuse who presented to the emergency department (ED) with lower urinary tract irritation and flank pain.</p>
      <sec>
        <title>Why should an emergency physician (EPs) be aware of this?</title>
        <p>Although previously unreported in United States ED literature, ketamine associated urinary dysfunction has become increasingly more common in EDs worldwide. Point-of-care ultrasound (POCUS) is an established modality for diagnosing hydronephrosis in the ED. EPs should consider using POCUS evaluate for hydronephrosis and bladder changes in ketamine abusers with lower urinary tract symptoms. The mainstay of treatment is discontinuing ketamine abuse.</p>
      </sec>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Twenty four-year-old Chinese-American male with a history of ketamine abuse (3&#x2013;5 times daily for 4 years), as well as cocaine and intravenous drug abuse, who presented to the ED with bilateral flank pain for 2 weeks. He noted 2 days of increasing pain, described as dull, waxing and waning. Associated symptoms included fever, chills, urinary frequency, dysuria, urgency, and more recently, urinary incontinence (requiring diapers). There was no history of weakness, bowel incontinence, or saddle anesthesia. On physical examination, the patient appeared uncomfortable and anxious. He complained of severe urgency, requiring frequent urination during the interaction. Mild bilateral costo-vertebral tenderness was noted, with an otherwise unremarkable abdominal and genitourinary examination. Neurologic examination was normal except for slight ataxia when performing tandem gait.</p>
      <p>The treating ED physician performed POCUS that revealed bilateral moderate hydroureteronephrosis (<xref ref-type="fig" rid="f1-wjem-15-382">Figure 1</xref>) and a contracted bladder with an irregular shape and areas of focal wall thickening (<xref ref-type="fig" rid="f2-wjem-15-382">Figure 2</xref>). The patient complained of frequency and urgency throughout the study and requested multiple times to pause the exam to urinate. Pain was elicited on suprapubic transducer application.</p>
      <p>Laboratory studies revealed an elevated creatinine (1.32 mg/dL) and urinalysis was positive for red blood cells (5&#x2013;10/high powered field), white blood cells (10&#x2013;25/hpf), few bacteria, protein (75 md/dL) and trace leukocyte esteraste. The remainder of his lab work (CBC, chemistry, coagulation profile) was negative.</p>
      <p>A computed tomography was ordered to rule out obstructive pathology and ultimately confirmed our POCUS findings. The final reading was &#x201C;moderate bilateral hydroureteronephrosis, and a small deformed urinary bladder.&#x201D; A urology consult was obtained. An outpatient workup was recommended for ketamine induced urinary tract disease. The patient was sent home with antibiotics for a urinary tract infection and encouraged to discontinue ketamine abuse. Upon review, the urine culture was negative and the patient was lost to follow up.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Ketamine is an <italic>N</italic>-methyl-<italic>D</italic>-aspartate receptor antagonist, used therapeutically as a dissociative anesthetic. Recreationally, it is frequently abused at raves, parties, and nightclubs. Patients with acute ketamine toxicity most often present to EDs with neurologic complaints such as confusion, loss of consciousness, agitation, and drowsiness. Recent literature suggests that many patients with chronic ketamine abuse also experience ketamine-associated urinary tract dysfunction (KAUD). To our knowledge, this is the first case of KAUD associated with bilateral hydronephrosis reported from a United States ED. This may be due to the fact that recreational ketamine occurs with much higher frequency outside the U.S., especially in East and South-East Asian countries.<xref rid="b1-wjem-15-382" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-wjem-15-382" ref-type="bibr">3</xref></p>
      <p>Ketamine associated urinary tract dysfunction (KAUD) is a syndrome first described by Shahani et al in 2007.<xref rid="b4-wjem-15-382" ref-type="bibr">4</xref> Since then, there has been over 110 cases reported in the literature.<xref rid="b5-wjem-15-382" ref-type="bibr">5</xref> About 20&#x2013;30% of patients who abuse ketamine suffer from lower urinary tract symptoms (LUTS).<xref rid="b6-wjem-15-382" ref-type="bibr">6</xref>,<xref rid="b7-wjem-15-382" ref-type="bibr">7</xref> Since most cases of KAUD have been reported in case reports, case series, and letters, the true prevalence of this disease is unknown. In a recent large community&#x2013;based study, Pal et al<xref rid="b1-wjem-15-382" ref-type="bibr">1</xref>, report a prevalence of LUTS of 30% among recent users. Furthermore, they conclude that recent ketamine users had increased odds of LUTS compared with non-users.</p>
      <p>The exact mechanism of ketamine associated urinary destruction is unknown. Some proposed mechanisms include: direct epithelial damage, microvascular injury, or immune-related damage to the urinary tract by ketamine or its metabolites.<xref rid="b6-wjem-15-382" ref-type="bibr">6</xref>,<xref rid="b9-wjem-15-382" ref-type="bibr">9</xref> Damage to the lower urinary tract damage is more common than upper urinary tract, although the latter occurs relatively frequently. These symptoms can be attributed to chronic inflammation, low bladder capacities, decreased bladder compliance, and/or detrusor overactivity.<xref rid="b9-wjem-15-382" ref-type="bibr">9</xref> Symptoms can become quite debilitating, causing frequent urination every 15&#x2013;45 minutes, as described in our case.</p>
      <p>Currently, this disease entity is a diagnosis of exclusion that typically occurs after ruling-out obstructive lesions. Patients with severe irritative lower urinary tract symptoms, a history of ketamine abuse, and no other cause for symptoms should be considered to have KAUD.<xref rid="b5-wjem-15-382" ref-type="bibr">5</xref> We believe point-of-care ultrasound is a safe, rapid, first-line imaging modality to consider in patients with suspected KAUD. POCUS for the detection of hydronephrosis in the ED has a sensitivity and specificity of 80&#x2013;87% and 82&#x2013;83%, respectively.<xref rid="b10-wjem-15-382" ref-type="bibr">10</xref>,<xref rid="b11-wjem-15-382" ref-type="bibr">11</xref> In addition, it is rapid, available, and free of ionizing radiation. One limitation of POCUS is the ability to rule out obstructing lesions and masses.</p>
      <p>Although the true incidence of positive findings of renal and bladder ultrasound in patients with KAUD is unknown, recent case series and reports suggest sonographic findings are frequent. Mason et al<xref rid="b12-wjem-15-382" ref-type="bibr">12</xref> reported that 12 of 23 patients in their case series had positive finding on renal ultrasound that included bladder wall thickening and small bladder volumes. Thirteen percent of these patients were found to have upper urinary tract involvement. Four patients were unable to fill their bladder and had to stop in the middle of the exam to empty their bladders.<xref rid="b12-wjem-15-382" ref-type="bibr">12</xref></p>
      <p>Chu et al<xref rid="b9-wjem-15-382" ref-type="bibr">9</xref> described 59 patients from two hospitals in Hong Kong with ketamine-associated cystitis. Fifty-one percent of these patients had unilateral hydronephrosis, while 44% had bilateral hydronephrosis. They report that most of these patients showed hydronephrosis and hydroureter that extended down to the vesiculo-uteric junction. It is postulated that upper tract involvement likely results from long-term decrease in bladder compliance.<xref rid="b9-wjem-15-382" ref-type="bibr">9</xref>,<xref rid="b12-wjem-15-382" ref-type="bibr">12</xref> Tsai et al<xref rid="b8-wjem-15-382" ref-type="bibr">8</xref>, reported 5 of 11 patients in their case series had bilateral hydronephrosis. These patients exhibited detrusor overactivity with small bladder capacities on urodynamic studies.<xref rid="b8-wjem-15-382" ref-type="bibr">8</xref></p>
      <p>Currently, the mainstay of therapy has been the discontinuation of ketamine use. Most patients have sterile pyuria where antibiotics are ineffective.<xref rid="b9-wjem-15-382" ref-type="bibr">9</xref> Other treatment modalities have included antimuscarinics and steroids, which have demonstrated limited efficacy for KAUD.<xref rid="b8-wjem-15-382" ref-type="bibr">8</xref> Surgical interventions (augmentation enterocystoplasty, ureteroplasty, cystectomy<xref rid="b9-wjem-15-382" ref-type="bibr">9</xref>, and ileal neobladder<xref rid="b12-wjem-15-382" ref-type="bibr">12</xref>) have been performed for patients with continued use and refractory symptoms.</p>
      <p>Ketamine associated urinary dysfunction is becoming an increasingly common and recognized syndrome associated with chronic ketamine abuse. Emergency physicians should consider the use of point-of-care ultrasound as a first-line imaging modality in patients with suspected KAUD. Patients should be advised to discontinue ketamine abuse and referred to a urologist to exclude alternative causes.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn2-wjem-15-382">
        <p>Full text available through open access at <ext-link ext-link-type="uri" xlink:href="http://escholarship.org/uc/uciem_westjem">http://escholarship.org/uc/uciem_westjem</ext-link></p>
      </fn>
      <fn id="fn3-wjem-15-382">
        <p><italic>Conflicts of Interest</italic>: By the <italic>West</italic>JEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. The authors disclosed none.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-wjem-15-382">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Balt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Erowid</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ketamine is associated with lower urinary tract signs and symptoms</article-title>
          <source>Drug Alcohol Depend</source>
          <year>2013</year>
          <volume>132</volume>
          <issue>1&#x2013;2</issue>
          <fpage>189</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="pmid">23474358</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-wjem-15-382">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Curan</surname>
              <given-names>HV</given-names>
            </name>
          </person-group>
          <article-title>Ketamine use: a review</article-title>
          <source>Addiction</source>
          <year>2012</year>
          <volume>107</volume>
          <fpage>27</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">21777321</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-wjem-15-382">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wood</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cottrell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recreational ketamine: from pleasure to pain</article-title>
          <source>BJU Int</source>
          <year>2011</year>
          <volume>107</volume>
          <fpage>1881</fpage>
          <lpage>1884</lpage>
          <pub-id pub-id-type="pmid">21314885</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-wjem-15-382">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shahani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Streutker</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dickson</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ketamine-associated ulcerative cystitis: a new clinical entity</article-title>
          <source>Urology</source>
          <year>2007</year>
          <volume>69</volume>
          <issue>5</issue>
          <fpage>810</fpage>
          <lpage>812</lpage>
          <pub-id pub-id-type="pmid">17482909</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-wjem-15-382">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Middela</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Ketamine-induced vesicopathy: a literature review</article-title>
          <source>Int J Clin Pract</source>
          <year>2011</year>
          <volume>65</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">21155941</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-wjem-15-382">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chu</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>WK</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The destruction of the lower urinary tract by ketamine abuse: a new syndrome?</article-title>
          <source>BJU Int</source>
          <year>2008</year>
          <volume>102</volume>
          <issue>11</issue>
          <fpage>1616</fpage>
          <lpage>1622</lpage>
          <pub-id pub-id-type="pmid">18680495</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-wjem-15-382">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muetzelfeltdt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kamboj</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Rees</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Journey through the K-hole: phenomenological aspects of ketamine use</article-title>
          <source>Drug Alcohol Depend</source>
          <year>2008</year>
          <volume>95</volume>
          <fpage>219</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="pmid">18355990</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-wjem-15-382">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Cha</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ketamine-associated bladder dysfunction</article-title>
          <source>Int J Urol</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>826</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="pmid">19659678</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-wjem-15-382">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chu</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Kwok</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>KM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Street ketamine &#x2013; associated bladder dysfunction: a report of ten cases</article-title>
          <source>Hong Kong Med J</source>
          <year>2007</year>
          <volume>13</volume>
          <issue>4</issue>
          <fpage>311</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="pmid">17592176</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-wjem-15-382">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watkins</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bowra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Validation of emergency physician ultrasound in diagnosing hydronephrosis in ureteric colic</article-title>
          <source>Emerg Med Australas</source>
          <year>2007</year>
          <volume>19</volume>
          <issue>3</issue>
          <fpage>188</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">17564683</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-wjem-15-382">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaspari</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Horst</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Emergency Ultrasound and Urinalysis in the Evaluation of Flank Pain</article-title>
          <source>Acad Emerg Med</source>
          <year>2005</year>
          <volume>12</volume>
          <fpage>1180</fpage>
          <lpage>1184</lpage>
          <pub-id pub-id-type="pmid">16282510</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-wjem-15-382">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mason</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cottrell</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Corrigan</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ketamine-associated lower urinary tract destruction: a new radiological challenge</article-title>
          <source>Clin Radiol</source>
          <year>2010</year>
          <volume>65</volume>
          <issue>10</issue>
          <fpage>795</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="pmid">20797465</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-wjem-15-382" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Longitudinal view of the right kidney showed moderate hydroureteronephrosis (arrow).</p>
      </caption>
      <graphic xlink:href="wjem-15-382-g001"/>
    </fig>
    <fig id="f2-wjem-15-382" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Transverse view of the bladder shows a small, irregularly shaped bladder wall with areas of focal thickening (arrow).</p>
      </caption>
      <graphic xlink:href="wjem-15-382-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
